YY/T 1449.3-2016Cardiovascular implants—Cardiac valve prostheses - Part 3: Heart valve substitutes implanted by transcatheter techniques (English PDF)
心血管植入物人工心脏瓣膜 第3部分:经导管植入式人工心脏瓣膜
This is a limited preview
Buy now to download the full PDF (85 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1449.3-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
January 26, 2016
Implementation date
January 1, 2017
Scope
YY/T 1449.3-2016 is the English-translated version of 心血管植入物人工心脏瓣膜 第3部分:经导管植入式人工心脏瓣膜.
YY/T 1449.3-2016 is the Chinese standard "Cardiovascular implants—Cardiac valve prostheses - Part 3: Heart valve substitutes implanted by transcatheter techniques".
Its scope clause reads: This section summarizes the use of risk management to validate/confirm transcatheter implantable artificial heart valves (hereinafter referred to as transcatheter valves) And the method of manufacturing, through the risk assessment to select the appropriate validation/validation test and methods.
These tests include transcatheter valves and their materials And physical, chemical, biological and mechanical properties of the components, as well as clinical pre-in vivo evaluation and clinical evaluation of transcatheter valve products.
This section specifies the operating conditions and performance requirements for transcatheter valves under the support of sufficient scientific and clinical data.
This section applies to all devices that are expected to be implanted into the human heart via a catheter valve. This section applies both to newly developed and improved transcatheter valves, as well as to implantable catheter valves and to determine the size of the catheter Required accessories, packaging and labels.
This part does not apply to artificial heart valves designed for implantation of artificial heart or cardiac assistive devices. This part does not apply to the valve in the valve structure of the artificial heart valve and allogeneic valve.
This section does not give specific requirements for non-conventional surgical implantation of artificial heart valves (eg, seamless). The requirements for such equipment should be Refer to this section and the relevant terms in GB 12279-2008.
Note. Appendix A describes the basic principles of the terms of this standard. Its clauses include normative reference documents.
Found what you need?
Document preview — YY/T 1449.3-2016
National Standard of the People's Republic of China
- ICS
- 11.040.40
- Classification
- C 35
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Preface
- Introduction
- 1 Scope
- 2 normative reference document
- 3 Terms and definitions
- 4 Abbreviations
- 5 Basic requirements
- 6 Device description
- 7 Design Verification Test and Analysis/Design Confirmation
- Appendix A (informative) Principles of the provisions of this standard
- Appendix B (informative) Tubular valve illustration, assembly and delivery system
- Appendix C (Normative Appendix) Packaging
- Appendix D (normative) Product labeling, instruction manual and training
- Appendix E (normative) Sterilization
- Appendix F (informative) Valve description
- Appendix G (informative) Hazard of catheter valves, associated failure modes and evaluation methods
- Appendix H (informative) Guidelines for in vitro testing of pediatric equipment
- Appendix I (informative) Procedures for the use of performance standards
- Appendix K (informative) Standard example for artificial heart valve material and component testing
- Appendix L (informative) Supported mechanical materials Original and treated mechanical properties
- Appendix M (informative) Corrosion assessment
- Appendix N (informative) Guidelines for the validation of hydrodynamic performance
- Appendix O (informative) Durability test
- Appendix P (informative) Fatigue Assessment
- Appendix Q (informative) Clinical in situ evaluation
- Appendix R (normative appendix) Classification of adverse events during clinical research
- Appendix S (informative) Echocardiographic program
1 Scope
This section summarizes the use of risk management to validate/confirm transcatheter implantable artificial heart valves (hereinafter referred to as transcatheter valves)
And the method of manufacturing, through the risk assessment to select the appropriate validation/validation test and methods. These tests include transcatheter valves and their materials
And physical, chemical, biological and mechanical properties of the components, as well as clinical pre-in vivo evaluation and clinical evaluation of transcatheter valve products.
This section specifies the operating conditions and performance requirements for transcatheter valves under the support of sufficient scientific and clinical data.
This section applies to all devices that are expected to be implanted into the human heart via a catheter valve.
This section applies both to newly developed and improved transcatheter valves, as well as to implantable catheter valves and to determine the size of the catheter
Required accessories, packaging and labels.
This part does not apply to artificial heart valves designed for implantation of artificial heart or cardiac assistive devices.
This part does not apply to the valve in the valve structure of the artificial heart valve and allogeneic valve.
This section does not give specific requirements for non-conventional surgical implantation of artificial heart valves (eg, seamless). The requirements for such equipment should be
Refer to this section and the relevant terms in GB 12279-2008.
Note. Appendix A describes the basic principles of the terms of this standard.
2 normative reference documents
The following documents are indispensable for the application of this document. For dated references, only the dated edition applies to this article
Pieces. For undated references, the latest edition (including all modifications) applies to this document.
ISO 10993-1 Biological evaluation of medical devices - Part 1. Evaluation and testing in risk management (Biologicalevalua- tionofmedicaldevices-Part 1. Evaluationandtestingwithinariskmanagementprocess)
ISO 10993-2 Biological evaluation of medical devices - Part 2. Animal welfare requirements (Biologicalevaluation ofmedical devices-Part 2. Animalw purchaserequirements)
ISO 11135-1 Sterilization of sterile ethylene glycol for medical care products - Part 1. Development, validation and validation of sterilization of medical devices
Conventional control requirements (Sterilization ofhealthcareproducts-Ethyleneoxide-Part 1. Requirementsfordevel- opment, validationandroutinecontrolofasterilizationprocessformedicaldevices)
ISO /T S11135-2 Sterilization of sterilization products for health care products - Part 2. ISO 11135-1 application guide (Sterilization ofhealthcareproducts-Ethyleneoxide-Part 2. GuidanceontheapplicationofISO 11135-1)
ISO 11137-1 Sterilization of sterilization products for medical care products - Part 1. Development, validation and routine of sterilization of medical devices
Control requirements (Sterilization ofhealthcare products-Radiation-Part 1. Requirementsfordevelopment, validationandroutinecontrolofasterilizationprocessformedicaldevices)
ISO 11137-2 Sterilization of sterilization products for health care products - Part 2. Establishment of sterilization dose (Sterilization ofhealth careproducts-Radiation-Part 2. constructedthesterilizationdose
ISO 11137-3 Sterilization of sterilization products for health care products - Part 3. Guidelines for dosimetry (Sterilization ofhealth careproducts-Radiation-Part 3. Guidanceondosimetricaspects)
ISO 11607-1 Packaging of final sterilized medical devices - Part 1. Materials, sterile barrier systems and packaging system requirements (Packa- gingforterminalysterilizedmedicaldevices-Part 1. Requirementsformaterials, sterilebarriersys- […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 85 pages — is available in the English PDF.
Referenced standards
Normative references
ISO 10993-1 · ISO 10993-2 · ISO 11135-1 · ISO/T S11135-2 · ISO 11137-1 · ISO 11137-2 · ISO 11137-3 · ISO 11607-1
Similar standards
How to Download YY/T 1449.3-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0479-2026 — Medical diagnostic X-ray tube assemblies and X-ray source assemblies - Determination of maximum symmetric radiation field
YY/T 0492-2026 — Implantable leads
Secure payment via Stripe
Payments accepted
YY/T 1449.3-2016
$2,218.00